News|Podcasts|October 25, 2022
Accelerating New Medicines: Innovation and Technology at Curia
Author(s)Curia
Curia is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
Related Content
Trending on PharmExec
1
AstraZeneca and Bristol Myers Squibb Held Merger Talks: Report
2
Pharmaceutical Executive Daily: AstraZeneca and Bristol Myers Squibb Held Merger Talks
3
Sandoz Agrees to $450 Million Settlement With 43 US States Over Generic Drug Antitrust Claims
4
Why Biologics R&D Platforms Are Failing Complex Modalities and What Must Change
5